These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1213887)

  • 21. Letter: Practolol.
    Galbraith JE
    Med J Aust; 1975 May; 1(21):664. PubMed ID: 1152725
    [No Abstract]   [Full Text] [Related]  

  • 22. Letter: Skin reactions to practolol.
    Wright P
    Br Med J; 1974 Jun; 2(5918):560. PubMed ID: 4276108
    [No Abstract]   [Full Text] [Related]  

  • 23. [Letter: Complications and side effects of long-term treatment with practolol].
    Bojdecki K
    Psychiatr Pol; 1976; 10(2):217-8. PubMed ID: 1273165
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of Eraldine].
    Pauchant M
    Lille Med; 1974 Oct; 19(8 Suppl 3):867-9. PubMed ID: 4463282
    [No Abstract]   [Full Text] [Related]  

  • 25. Letter: cutaneous and ocular reactions to practolol.
    Raftery EB
    Br Med J; 1974 Dec; 4(5945):653. PubMed ID: 4548368
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter: Skin reactions associated with propranolol.
    Cochran RE; Thomson J; McQueen A; Beevers DG
    Arch Dermatol; 1976 Aug; 112(8):1173-4. PubMed ID: 952541
    [No Abstract]   [Full Text] [Related]  

  • 27. Fibrinous peritonitis: a complication of practolol therapy.
    Windsor WO; Durrein F; Dyer NH
    Br Med J; 1975 Apr; 2(5962):68. PubMed ID: 1131549
    [No Abstract]   [Full Text] [Related]  

  • 28. Sclerosing peritonitis due to practolol.
    Thompson RP; Jackson BT
    Br Med J; 1977 May; 1(6073):1393-4. PubMed ID: 861650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of eye complaints and rashes among patients receiving practolol and propranolol.
    Skegg DC; Doll R
    Lancet; 1977 Sep; 2(8036):475-8. PubMed ID: 70688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Oculocutaneous reactions following treatment with betablockers].
    Erikssen J
    Tidsskr Nor Laegeforen; 1976 Aug; 96(24):1288-9. PubMed ID: 9706
    [No Abstract]   [Full Text] [Related]  

  • 31. [Sclerosing peritonitis and practolol (author's transl)].
    Hess T; Stucki P
    Med Klin; 1977 Jul; 72(28-29):1220-4. PubMed ID: 887049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse reaction to the beta-adrenergic blocking drugs.
    Brigden WD; Almeyda J
    Br J Dermatol; 1976 Sep; 95(3):335-8. PubMed ID: 974021
    [No Abstract]   [Full Text] [Related]  

  • 33. Test and teach. Number twenty-one. Diagnosis: practolol induced sclerosing peritonitis.
    Chang AR
    Pathology; 1980 Jan; 12(1):32-33, 131-3. PubMed ID: 7375145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Actual late effects. Skin, eye and hearing changes during treatment with practolol (Eraldin)].
    Ugeskr Laeger; 1975 Apr; 137(18):1016-7. PubMed ID: 124969
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy.
    Behan PO; Behan WM; Zacharias FJ; Nicholls JT
    Lancet; 1976 Nov; 2(7993):984-7. PubMed ID: 62263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A ranked presentation of the MHRA/CSM (Medicines & Health Care Regulatory Agency/Committee on Safety of Medicines) Drug Analysis Print (DAP) data on practolol.
    Mann RD
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):705-10. PubMed ID: 16088980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of practolol in the treatment of angina pectoris.
    Sen PK; Mukerjee AB
    J Indian Med Assoc; 1974 Oct; 63(8):260-1. PubMed ID: 4216606
    [No Abstract]   [Full Text] [Related]  

  • 38. Practolol-induced autoantibodies and their relation to oculo-cutaneous complications.
    Jachuck SJ; Stephenson J; Bird T; Jackson FS; Clark F
    Postgrad Med J; 1977 Feb; 53(616):75-7. PubMed ID: 141660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Our experience with a new beta-adrenergic blocking agent (Practolol) in angina pectoris].
    Rodríguez Alvarez J; Vázquez Guzmán D; Benot Moreno E
    Rev Esp Cardiol; 1973; 26(5):383-8. PubMed ID: 4588379
    [No Abstract]   [Full Text] [Related]  

  • 40. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol).
    Brown P; Baddeley H; Read AE; Davies JD; McGarry J
    Lancet; 1974 Dec; 2(7895):1477-81. PubMed ID: 4140395
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.